Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75
Document › Details

ASIT Biotech S.A.. (1/25/18). "Press Release: ASIT Biotech Successfully Completes the First Tranche of Its Capital Increase and Raises €9.4 Million [Not for United States, Australia, Canada, Japan, et al.]". Brussels.

Organisations Organisation ASIT Biotech S.A. (Euronext: ASIT – BE0974289218)
  Organisation 2 NewCap. – Investor Relations & Financial Communications
Products Product gp- ASIT+™ grass pollen rhinitis immunotherapy
  Product 2 investment banking
Index term Index term ASIT Biotech–SEVERAL: investment, 201801 private placement capital increase first tranche €9.4m w 2.46m new shares at €3.83/share
Persons Person Legon, Thierry (ASIT Biotech 201605 CEO)
  Person 2 Orešanský, Dušan (NewCap 201404)

Record changed: 2018-02-28


Picture [LSUS] – The Business Web Portal 650x65px

More documents for ASIT Biotech S.A. (Euronext: ASIT – BE0974289218)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

» top